Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk-factors

被引:33
作者
Guckelberger, O [1 ]
Byram, A [1 ]
Klupp, J [1 ]
Neumann, UP [1 ]
Glanemann, M [1 ]
Stockmann, M [1 ]
Neuhaus, R [1 ]
Neuhaus, P [1 ]
机构
[1] Charite, Dept Gen Visceral & Transplantat Surg, D-13353 Berlin, Germany
关键词
arterial hypertension; coronary heart disease; diabetes mellitus; lipid metabolism; liver transplantation; overweight;
D O I
10.1111/j.1432-2277.2005.00174.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Increased prevalence of cardiovascular risk-factors in liver transplant recipients compared with pretransplant and standard population data has been acknowledged. The impact of risk-profiles on cardiovascular event rates or death, however, has not yet been established. Here we evaluate the development of risk-factors during a prospective follow-up of 10 years in 302 patients and compare numbers of coronary events with data from the German Prospective Cardiovascular Munster (PROCAM)-Score population. Prevalence of overweight (17% vs. 27%), hypertension (70% vs. 80%), and diabetes (21% vs. 25%) increased from early to late after transplantation, while elevated serum cholesterol (64% vs. 37%) and triglycerides (40% vs. 21%) became less frequent. Cardiovascular risk-profiles favoring tacrolimus over ciclosporin A based immunosuppression early after transplantation converged over time. Increased risk-scores in liver transplant recipients matched with score standardized event rates in the PROCAM population (ratio: 1.11, 95% CI: 0.53-2.03), nine events were predicted for the transplant population and oppose 10 events observed. Thus, indicating a reflection of increased cardiovascular risk-profiles in corresponding numbers of cardiovascular events.
引用
收藏
页码:967 / 974
页数:8
相关论文
共 29 条
[1]   Ten years of liver transplantation - An evolving understanding of late graft loss [J].
Abbasoglu, O ;
Levy, MF ;
Brkic, BB ;
Testa, G ;
Jeyarajah, DR ;
Goldstein, RM ;
Husberg, BS ;
Gonwa, TA ;
Klintmalm, GB .
TRANSPLANTATION, 1997, 64 (12) :1801-1807
[2]   Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study [J].
Assmann, G ;
Cullen, P ;
Schulte, H .
CIRCULATION, 2002, 105 (03) :310-315
[3]   Liver transplantation in cirrhotic patients with diabetes mellitus:: Midterm results, survival, and adverse events [J].
Blanco, JJ ;
Herrero, JI ;
Quiroga, J ;
Sangro, B ;
Gómez-Manero, N ;
Pardo, F ;
Cienfuegos, JA ;
Prieto, J .
LIVER TRANSPLANTATION, 2001, 7 (03) :226-233
[4]   Prevention of post-transplant cardiovascular disease - Report and recommendations of an ad hoc group [J].
Bostom, AD ;
Brown, RS ;
Chavers, BM ;
Coffman, TM ;
Cosio, FG ;
Culver, K ;
Curtis, JJ ;
Danovitch, GM ;
Everson, GT ;
First, MR ;
Garvey, C ;
Grimm, R ;
Hertz, MI ;
Hricik, DE ;
Hunsicker, LG ;
Ibrahim, H ;
Kasiske, BL ;
Kennedy, M ;
Klag, M ;
Knatterud, ME ;
Kobashigawa, J ;
Lake, JR ;
Light, JA ;
Matas, AJ ;
McDiarmid, SV ;
Miller, LW ;
Payne, WD ;
Rosenson, R ;
Sutherland, DER ;
Tejani, A ;
Textor, S ;
Valantine, HA ;
Wiesner, RH .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (06) :491-500
[5]  
Canzanello V J, 1997, Liver Transpl Surg, V3, P1
[6]   Late hypertension after liver transplantation: A comparison of cyclosporine and tacrolimus (FK 506) [J].
Canzanello, VJ ;
Textor, SC ;
Taler, SJ ;
Schwartz, LL ;
Porayko, MK ;
Wiesner, RH ;
Krom, RAF .
LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (04) :328-334
[7]   Serum cholesterol changes in long-term survivors of liver transplantation:: A comparison between cyclosporine and tacrolimus therapy [J].
Charco, R ;
Cantarell, C ;
Vargas, V ;
Capdevila, L ;
Lázaro, JL ;
Hidalgo, E ;
Murio, E ;
Margarit, C .
LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (03) :204-208
[8]   Weight change and obesity after liver transplantation: Incidence and risk factors [J].
Everhart, JE ;
Lombardero, M ;
Lake, JR ;
Wiesner, RH ;
Zetterman, RK ;
Hoffnagle, JH .
LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (04) :285-296
[9]   The effects of maintenance doses of FK506 versus Cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation [J].
Fernandez, LA ;
Lehmann, R ;
Luzi, L ;
Battezzati, A ;
Angelico, MC ;
Ricordi, C ;
Tzakis, A ;
Alejandro, R .
TRANSPLANTATION, 1999, 68 (10) :1532-1541
[10]   Cardiovascular risk factors in 116 patients 5 years or more after liver transplantation [J].
Fernández-Miranda, C ;
Sanz, M ;
dela Calle, A ;
Loinaz, C ;
Gómez, R ;
Jiménez, C ;
García, I ;
de la Cámara, AG ;
Moreno, E .
TRANSPLANT INTERNATIONAL, 2002, 15 (11) :556-562